SEC Tracker
Get the app

Jazz Pharmaceuticals JAZZ

D Gala Renee (Officer) plans to sell 2,000 JAZZ shares, about $472,800

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Oct 6, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Restricted Stock
  4. 10b5-1 plan adopted: Jun 4, 2026

All of D Gala Renee's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Jazz Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  2. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  3. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025
  4. Ionis Pharmaceuticals IONS public float $5.3B, Jun 30, 2025
  5. Prestige Consumer Healthcare PBH public float $3.0B, Sep 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.